High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma
Nicholas C. Wolff(The University of Texas Southwestern Medical Center), James Brugarolas(The University of Texas Southwestern Medical Center)
Cited by 34
Related Papers
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
|Nature Medicine|2004|956
Regulation of TFEB and V-ATPases by mTORC1
|The EMBO Journal|2011|457
Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes
|Nature Genetics|2014|359
Multistep regulation of TFEB by MTORC1
|Autophagy|2017|229
Pancreatic tropism of metastatic renal cell carcinoma
|JCI Insight|2020|88